MAPK3 and rheumatoid arthritis: ERK1/2 signaling has also been implicated in several diseases that are characterized by a chronic state of inflammation such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and the progressive form of osteoarthritis (OA).